Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial
Laure Peter‐Derex, Frédéric Philippeau, Pierre Garnier, Nathalie André‐Obadia, Sébastien Boulogne, Hélène Catenoix, Philippe Convers, Laure Mazzola, Michel Gouttard, Maud Esteban, Julia Fontaine, Laura Mechtouff, Elodie Ong, Tae‐Hee Cho, Norbert Nighoghossian, Nathalie Perreton, Anne Termoz, Julie Haesebaert, Anne‐Marie Schott, Muriel Rabilloud, C. Pivot, C. Dhelens, Andrea Filip, Yves Berthezène, Sylvain Rheims, Florent Boutitie, Laurent Derex
Topics & Concepts
MedicineLevetiracetamPlaceboClinical endpointRandomized controlled trialAnesthesiaPopulationEpilepsyAdverse effectSubclinical infectionStroke (engine)Clinical trialPediatricsInternal medicinePsychiatryEngineeringEnvironmental healthPathologyMechanical engineeringAlternative medicineIntracerebral and Subarachnoid Hemorrhage ResearchEpilepsy research and treatmentAcute Ischemic Stroke Management